closerlook, inc. is a digital marketing agency that helps pharmaceutical marketers build better relationships with their best customers. We take a practical approach to innovation that folds future planning into the processes that are already working. We develop product offerings that both increase customer insight—through new technology, data collection, in-depth analysis and reporting—and improve marketing communication with customers through responsive, content-rich campaigns that are integrated across a wide range of channels. Through the right combination of software and services—strategy, creative, analytics, technology and client services—closerlook enables enterprise-level relationship marketing and brand-level digital marketing.
closerlook’s creative, analytics and technology offerings enable more effective and efficient multichannel marketing campaigns. We apply technology to turn data into actionable insights. This means we help you deliver the most relevant messages to customers, when and where they want it.
- Company Resources
Marketing Technology for Pharma: An overview of some of today’s most talked about tech
Michael Tapson, closerlook’s Chief Technology Officer, shares his thoughts on the future of pharmaceutical digital marketing. His white paper addresses emerging trends in the fields marketers need to be familiar with, including the internet of things, big data, customer relationship management, where email is headed, machine learning and artificial intelligence, virtual and augmented reality and fitness measuring wearables.
Digital know-how meets relationship marketing
Seattle-based Appature has signed up several healthcare marketing agencies and business service firms to use its cloud-based relationship marketing platform.
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Novartis considers new sales model for experimental cancer therapy